MONOKET

LOE Approaching

isosorbide mononitrate

NDAORALTABLET
Approved
Jun 1993
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
3

Mechanism of Action

CLINICAL PHARMACOLOGY: Isosorbide mononitrate is the major active metabolite of isosorbide dinitrate (ISDN), and most of the clinical activity of the dinitrate is attributable to the mononitrate. The principal pharmacological action of isosorbide mononitrate is relaxation of vascular smooth muscle…

Pharmacologic Class:

Nitrate Vasodilator

Clinical Trials (3)

NCT07121634N/AActive Not Recruiting

Cervical Ripening With Misoprostol vs Isosorbide Mononitrate ; A Parallel -Arm Randomized Controlled Trial

Started Jan 2024
NCT04051957Phase 2Terminated

Isosorbide Mononitrate For Anti-Vascular Endothelial Growth Factor (VEGF) Induced Kidney Injury

Started Sep 2019
9 enrolled
Kidney InjuryProteinuriaHypertension
NCT00871871Phase 1Completed

Multiple Dose Effects of Hydrochlorothiazide and Isosorbide Mononitrate on Glucose Homeostasis (MK-0000-117)(Completed)

Started Mar 2009
64 enrolled
Hypertension